Skip to main content

Table 2 Patient’s age and liver function before TACE

From: Efficacy and safety analysis of dexamethasone-lipiodol emulsion in prevention of post-embolization syndrome after TACE: a retrospective analysis

Group

Mean

Std. deviation

t test (P value)

Age

 TACE

47.3

11.6

0.331

 TACE + dexamethasone

48.8

12.5

 

ALT

 TACE

42.6

17.8

0.155

 TACE + dexamethasone

47.1

19.0

 

AST

 TACE

41.3

17.8

0.093

 TACE + dexamethasone

45.4

17.7

 

ALP

 TACE

90.7

29.1

0.389

 TACE + dexamethasone

93.6

23.7